October 2021 Issue

GO TO FULL ISSUE

Get evidence-based advice on drug information and current guidelines, plus the state-specific CE you need. Subscribe. Pharmacist's Letter

Med Updates

Kloxxado
naloxone
New higher strength (8 mg) nasal spray for emergency treatment of opioid overdose

Kerendia
finerenone
A non-steroidal mineralocorticoid receptor antagonist for patients with chronic kidney disease associated with type 2 diabetes

Azstarys
serdexmethylphenidate/
dexmethylphenidate
A stimulant for ADHD

MORE MED UPDATES